Ann: March 2019 Quarterly Operational Update and App4C, page-78

i think it would be interesting to know to what if any pyc ip or libraries they are still using. Surely pyc equity is one thing but i believe we still retain rights to anything used from our library so in theory that could still be a second income stream if anything was licensed,??
I assume they would probably just do what we did with imyc though in just gind something that works then make the slightest adjustment to it so it still works but is no longer pyc ip? Ie the difference between omomyc and imyc? Im curious to know how different those two myc inhibitors actually were.